← Back to Search

Mental Health Screening for Depression and Dementia in Seniors

Phase 1

Waitlist Available

Led By Joel Sadavoy, M.D.

Research Sponsored by Mount Sinai Hospital, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will test the feasibility of mental health screening and service utilization in a community sample of Chinese seniors.

Who is the study for?

This trial is for Chinese seniors living in the community who can understand and agree to participate. It's not for those who can't grasp what the study involves or its potential risks and benefits, which means they're unable to give informed consent.Check my eligibility

What is being tested?

The study looks at how acceptable mental health screening is for these seniors, checks if people use mental health services more after being screened, and sees if knowing about a mental illness changes their search for help.See study design

What are the potential side effects?

Since this trial focuses on screening rather than medication or interventions that could cause physical side effects, it does not have typical medical side effects. However, participants may experience emotional discomfort discussing personal mental health issues.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of confirmed psychiatric diagnoses in intervention group

Rate of help seeking in intervention group

Type of intervention received

Do I qualify?Apply below to find out

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Mount Sinai Hospital, CanadaLead Sponsor

196 Previous Clinical Trials

67,508 Total Patients Enrolled

9 Trials studying Depression

1,990 Patients Enrolled for Depression

Joel Sadavoy, M.D.Principal InvestigatorMt. Sinai Hospital, Toronto, Canada

Media Library

Mental Health Screening Clinical Trial Eligibility Overview. Trial Name: NCT00433238 — Phase 1

Depression Clinical Trial 2023: Mental Health Screening Highlights & Side Effects. Trial Name: NCT00433238 — Phase 1

Mental Health Screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT00433238 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to take part in this research project?

"To qualify for this research, volunteers must be between 55 and 85 years old with a diagnosis of dementia. This trial is currently seeking approximately one hundred participants."

Answered by AI

Is this research endeavor still looking for participants?

"According to the information on clinicaltrials.gov, this study is not presently accepting patients into its trial. This research was first posted in March 2007 and its last update occurred in February of that same year. Despite this data, 1216 other trials are seeking participants at present time."

Answered by AI

Is this therapeutic procedure secure for the people receiving it?

"Given the limited amount of evidence present, this potential treatment has been rated a 1 on our safety scale. As it is in Phase 1 clinical trials, there is only minimal data that suggests its efficacy and security."

Answered by AI